Sponsor

University of Liverpool

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Liverpool appears in 77 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials77
Recruiting shown5
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
The Role of Ectopic Fat and Heart Attack Risk in HIVNCT06784154 · lead sponsor · 2024-08-01
RECRUITING
Doravirine Dose Optimisation in PregnancyNCT05630638 · lead sponsor · 2023-10-10
RECRUITING
Food Menu Labelling Effects on Individuals With Eating Disorders and Other Mental Health Conditions.NCT07809295 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Fast Food Online Delivery Purchase Behaviour in the Presence and Absence of Price-based IncentivesNCT07368881 · lead sponsor · 2026-02-24
COMPLETED
Nutri-score Labels on the Nutritional Quality of Out-of-home Food SelectionNCT07423845 · lead sponsor · 2025-12-08
COMPLETED
Investigating the Effects of Calorie Information and Serving Size of Alcohol Products on Alcohol Consumption.NCT07103967 · lead sponsor · 2025-07-30
COMPLETED
Differing Completion Rates of DIABETES Education on Patient Reported OutcomesNCT06419907 · lead sponsor · 2024-05-16
COMPLETED
Investigating the Effects of Altering Portion Size Reduction Awareness on Compensatory Eating BehaviourNCT06119295 · lead sponsor · 2023-11-01
COMPLETED
Multivariate Biomarker Study for Sarcopenia in Heart FailureNCT06217640 · lead sponsor · 2023-08-01
ACTIVE_NOT_RECRUITING
Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and PostpartumNCT05766007 · lead sponsor · 2023-08-01
COMPLETED
Use of Air Purifiers to Improve Respiratory Health in ChildrenNCT05817357 · lead sponsor · 2023-05-02
COMPLETED
Pricing Interventions Based on Energy Content in RestaurantsNCT05818345 · lead sponsor · 2023-03-27
TERMINATED
The Impact of Food Reformulation on Energy IntakeNCT05744050 · lead sponsor · 2023-02-13
COMPLETED
Multi-morbidity Screening in People With Type 2 Diabetes and Pre DiabetesNCT06053177 · lead sponsor · 2023-01-25
ACTIVE_NOT_RECRUITING
SSS and the Impact of Portion Size on Daily Energy IntakeNCT05399836 · lead sponsor · 2022-05-30
COMPLETED
SEP and the Impact of Portion Size on Daily Energy IntakeNCT05173376 · lead sponsor · 2021-10-25
COMPLETED
Low-Calorie Diet in People With Prediabetes/Metabolic SyndromeNCT04786418 · lead sponsor · 2021-06-01
COMPLETED
Increasing Availability of Lower Energy Meals on Food Choice and IntakeNCT04893213 · lead sponsor · 2021-04-13
COMPLETED
Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral LoadNCT04121195 · lead sponsor · 2020-10-30
COMPLETED
How Does Antiretroviral Therapy Affect Coronary Atherosclerosis: a Serial CT StudyNCT03986697 · lead sponsor · 2020-02-04
WITHDRAWN
A Randomized Trial of Oral Misoprostol Alone Versus Oral Misoprostol Followed by Oxytocin for Labour InductionNCT03749902 · lead sponsor · 2020-01-06
COMPLETED
qMOLI- A Qualitative Assessment of Misoprostol or Oxytocin for Labour InductionNCT04037683 · lead sponsor · 2019-10-18
COMPLETED
Pharmacokinetics of Atazanavir in Special PopulationsNCT03923231 · lead sponsor · 2019-09-02
COMPLETED
Increasing Availability of Lower Energy Meals vs. Menu Energy Labelling on Food ChoiceNCT04336540 · lead sponsor · 2019-08-01
COMPLETED
Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management ServiceNCT03638895 · lead sponsor · 2018-11-28
COMPLETED
Dolutegravir in Pregnant HIV Mothers and Their NeonatesNCT03249181 · lead sponsor · 2018-01-22
COMPLETED
Attentive Eating for Weight LossNCT03602001 · lead sponsor · 2017-09-07
COMPLETED
Remembered Meal Satisfaction, Satiety and Later Snack Food IntakeNCT03750019 · lead sponsor · 2017-08-07
COMPLETED
Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot StudyNCT02245022 · lead sponsor · 2017-03-14
COMPLETED
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes PatientsNCT02616666 · lead sponsor · 2016-08-25
COMPLETED
Dolutegravir Interactions With Artemisinin-based Combination TherapiesNCT02242799 · lead sponsor · 2015-06-01
COMPLETED
Thinking Healthy Program - Peer Delivered (Pakistan)NCT02111915 · lead sponsor · 2014-10-01
COMPLETED
Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDSNCT02155101 · lead sponsor · 2014-05-01
COMPLETED
Induction With Foley OR Misoprostol (INFORM) StudyNCT01801410 · lead sponsor · 2013-12-01
COMPLETED
The Mouth Matters in Mental Health Trial -2NCT07470437 · collaborator · 2026-05-01
RECRUITING
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral TreatmentNCT06267508 · collaborator · 2024-04-30
RECRUITING
Integrated Approach in Frail Older People with Atrial FibrillationNCT06775028 · collaborator · 2024-04-11
RECRUITING
Mental Health Mission Mood Disorder Cohort StudyNCT07189689 · collaborator · 2025-10-01
NOT_YET_RECRUITING
A Pharmacokinetic-pharmacodynamic Modeling and Simulation Study of Subcutaneous Infliximab in Patients With Inflammatory Bowel DiseaseNCT07120152 · collaborator · 2025-09-01
NOT_YET_RECRUITING
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenNCT05773183 · collaborator · 2023-03-12
UNKNOWN
A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)NCT04120415 · collaborator · 2022-06-21
COMPLETED
Chocolate and Physical Exercise to Reduce Malnutrition in Pre-dementia Aged PeopleNCT05343611 · collaborator · 2022-05-01
UNKNOWN
Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIVNCT04910711 · collaborator · 2021-10-21
UNKNOWN
Muscle in Obesity: Imaging, Function and microRNANCT04300504 · collaborator · 2021-09-01
COMPLETED
Evaluation of Safety and Dosing of a Vitamin C Bundle for Sepsis Treatment in AfricaNCT04999137 · collaborator · 2021-09-01
UNKNOWN
Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral TherapyNCT04385719 · collaborator · 2021-05-05
COMPLETED
CCP Cancer UK Companion StudyNCT04603105 · collaborator · 2021-02-28
ACTIVE_NOT_RECRUITING
Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical OutcomeNCT04622761 · collaborator · 2021-01-15
UNKNOWN
Work Package 2 Phase 1 - Beverages StudyNCT04483180 · collaborator · 2020-08-14
COMPLETED
COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited SettingsNCT04371835 · collaborator · 2020-08-12
COMPLETED
Sweeteners and Sweetness Enhancers: Prolonged Effects on Health, Obesity and SafetyNCT04226911 · collaborator · 2020-01-30
COMPLETED
Longitudinal Assessment of Multiple Organs in Patients With Type 2 DiabetesNCT04114682 · collaborator · 2020-01-27
ACTIVE_NOT_RECRUITING
The CHAPS Trial: Combined HIV Adolescent PrEP and PreventionNCT03986970 · collaborator · 2019-11-11
COMPLETED
Prevention of Primary Foot Ulcers in High-risk Diabetes PatientsNCT03958539 · collaborator · 2019-09-01
TERMINATED
Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy VolunteersNCT03894124 · collaborator · 2019-06-12
COMPLETED
Male Partner-assisted Contact Tracing for HIV and Tuberculosis in MalawiNCT04285905 · collaborator · 2019-04-10
TERMINATED
A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in MalawiNCT03519425 · collaborator · 2018-11-15
UNKNOWN
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive ImplantNCT03589040 · collaborator · 2018-09-25
UNKNOWN
Darunavir and Rilpivirine Interactions With Levonorgestrel ImplantNCT03589027 · collaborator · 2018-08-07
UNKNOWN
Evaluation of a Physical Activity Referral SchemeNCT03490747 · collaborator · 2018-03-12
COMPLETED

Drugs studied in this sponsor's trials

26 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Liverpool as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
dolutegravir3
efavirenz3
darunavir2
doravirine2
levonorgestrel2
nevirapine2
oxytocin2
rilpivirine2
dolutegravir RxCUI 1433868 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 3 trials efavirenz RxCUI 195085 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 3 trials darunavir RxCUI 460132 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials doravirine RxCUI 2055755 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 2 trials levonorgestrel RxCUI 6373 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials nevirapine RxCUI 53654 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials oxytocin RxCUI 7824 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials rilpivirine RxCUI 1102270 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials amphotericin B RxCUI 732 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial ascorbic acid RxCUI 1151 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial Biktarvy RxCUI 1999668 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial cabazitaxel RxCUI 996051 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial dapagliflozin RxCUI 1488564 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial etonogestrel 68 MG Drug Implant RxCUI 389221 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial fluconazole RxCUI 4450 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial gonadorelin RxCUI 6384 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial misoprostol RxCUI 42331 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial misoprostol Oral Tablet RxCUI 372941 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial norethindrone enanthate RxCUI 31984 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial pirfenidone RxCUI 1592254 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial remdesivir RxCUI 2284718 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial tamoxifen RxCUI 10324 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial tenofovir RxCUI 117466 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator43
lead sponsor34
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.